The same effect, but in a different mechanism, was reported with miR-200b-3p in colorectal cancer, where, via targeting TUBB3, it reduced resistance to oxaliplatin and promoted apoptosis and growth inhibition in resistant cancer cells (247). This evidence concerns the gene TUBB3 and colorectal cancer.